Imatinib (EBC-06061)
Back
Product details:
CAS
152460-10-1
Purity
95%
6-Methyl-N1-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine inhibits Bcr-Abl tyrosine protein kinase, IC50 = 1.5 µM.
Properties
Name
6-Methyl-N1-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
Smiles
CC=1C=CC(N)=CC1NC=2N=CC=C(N2)C=3C=CC=NC3
Targets
Please log in to see this information
The impurity for drugs
SDS
Imatinib impurity F | Imatinib impurity F CRS | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-aminopyrimidine | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)pyrimidine-2-amine
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
Imatinib impurity F | Imatinib impurity F CRS | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-aminopyrimidine | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)pyrimidine-2-amine
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.